Senping Cheng

Senping Cheng has worked for three companies in the past decade. Senping began their career in 2010 as the CEO of Pan-Pacific Biopharma Inc. In 2014, they moved to Gens Pharma, Inc. to take on the role of President. Senping then became the CEO of Triastek, Inc. in 2015.

Senping Cheng obtained a Doctor of Philosophy (PhD) in Toxicology from the University of Kentucky between 2006 and 2010.